| Evans syndrome in adults‐incidence, prevalence, and survival in a nationwide cohort DL Hansen, S Möller, K Andersen, D Gaist, H Frederiksen American journal of hematology 94 (10), 1081-1090, 2019 | 60 | 2019 |
| Splenomegaly–Diagnostic validity, work-up, and underlying causes E Curovic Rotbain, D Lund Hansen, O Schaffalitzky de Muckadell, ... PloS one 12 (11), e0186674, 2017 | 46 | 2017 |
| Identifying traffic accident black spots with Poisson-Tweedie models B Debrabant, U Halekoh, WH Bonat, DL Hansen, J Hjelmborg, J Lauritsen Accident Analysis & Prevention 111, 147-154, 2018 | 44 | 2018 |
| Increasing incidence and prevalence of acquired hemolytic anemias in Denmark, 1980–2016 DL Hansen, S Möller, K Andersen, D Gaist, H Frederiksen Clinical Epidemiology, 497-508, 2020 | 36 | 2020 |
| Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses TA Knudsen, V Skov, K Stevenson, L Werner, W Duke, C Laurore, ... Blood advances 6 (7), 2107-2119, 2022 | 35 | 2022 |
| Evans syndrome in adults: an observational multicenter study B Fattizzo, M Michel, JA Giannotta, DL Hansen, M Arguello, E Sutto, ... Blood advances 5 (24), 5468-5478, 2021 | 31 | 2021 |
| Data‐driven analysis of JAK2V617F kinetics during interferon‐alpha2 treatment of patients with polycythemia vera and related neoplasms RK Pedersen, M Andersen, TA Knudsen, Z Sajid, J Gudmand‐Hoeyer, ... Cancer medicine 9 (6), 2039-2051, 2020 | 22 | 2020 |
| Long-term efficacy and safety of recombinant interferon alpha-2 vs. hydroxyurea in polycythemia vera: preliminary results from the three-year analysis of the daliah trial-a … TA Knudsen, DL Hansen, LF Ocias, OW Bjerrum, M Brabrand, D El Fassi, ... Blood 132, 580, 2018 | 21 | 2018 |
| Evans syndrome in children below 13 years of age–a nationwide population-based cohort study N Mannering, DL Hansen, H Frederiksen PLoS One 15 (4), e0231284, 2020 | 18 | 2020 |
| Positive predictive value of diagnosis coding for hemolytic anemias in the Danish National Patient Register DL Hansen, UM Overgaard, L Pedersen, H Frederiksen Clinical epidemiology, 241-252, 2016 | 18 | 2016 |
| Epidemiology of secondary warm autoimmune haemolytic anaemia—a systematic review and meta-analysis S Tranekaer, DL Hansen, H Frederiksen Journal of Clinical Medicine 10 (6), 1244, 2021 | 15 | 2021 |
| Prevalence of congenital hemolytic disorders in Denmark, 2000–2016 DL Hansen, A Glenthøj, S Möller, BJ Biemond, K Andersen, D Gaist, ... Clinical Epidemiology, 485-495, 2020 | 14 | 2020 |
| Comparison of image quality in chest, hip and pelvis examinations between mobile equipment in nursing homes and static indirect radiography equipment in the hospital H Precht, DL Hansen, BM Ring-Pedersen, LFM Hansen, D Waaler, ... Radiography 26 (2), e31-e37, 2020 | 12 | 2020 |
| Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine M Gigoux, MO Holmström, R Zappasodi, JJ Park, S Pourpe, CC Bozkus, ... Science translational medicine 14 (649), eaba4380, 2022 | 11 | 2022 |
| Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow‐up DL Hansen, S Möller, H Frederiksen European journal of haematology 109 (1), 10-20, 2022 | 10 | 2022 |
| Seasonal variation in the incidence of cold agglutinin disease in Norway, Denmark, and Italy DL Hansen, S Berentsen, B Fattizzo, PL Hansen, W Barcellini, ... American Journal of Hematology 96 (7), E262-E265, 2021 | 9 | 2021 |
| S1609 THREE‐YEAR ANALYSIS OF THE DALIAH TRIAL‐A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA‐2 VS. HYDROXYUREA IN PATIENTS WITH … TA Knudsen, D Lund Hansen, L Frans Ocias, O Weis Bjerrum, ... HemaSphere 3, 741-742, 2019 | 7 | 2019 |
| Thrombotic thrombocytopenic purpura DL Hansen, AC Nilsson, H Frederiksen Ugeskrift for laeger 183 (42), 2021 | 5 | 2021 |
| Identification of black spots for traffic injury in road intersections dependence of injury definition D Hansen, JM Lauritsen Injury Prevention 16 (Suppl 1), A261-A261, 2010 | 5 | 2010 |
| Interferon alpha‐2 treatment reduces circulating neutrophil extracellular trap levels in myeloproliferative neoplasms L Massarenti, TA Knudsen, C Enevold, V Skov, L Kjær, MK Larsen, ... British Journal of Haematology 202 (2), 318-327, 2023 | 4 | 2023 |
